Agoracom: Small Cap Investment - Zenith Epigenetics - Re: Zenith to present at Biotech Showcase in January

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Zenith to present at Biotech Showcase in January

BearDownAZ

Dec 08, 2016 02:56PM

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith to present at Biotech Showcase in January

in response to

Zenith to present at Biotech Showcase in January

BearDownAZ

posted on Dec 14, 2016 03:58PM

Also, Zenith (and Resverlogix) are both on the schedule for 30 minute CEO presentations at the BIO CEO and Investor Conference in New York, February 13-14. Thanks to JK on the Stockhouse board for posting about this.